{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:11:33Z","timestamp":1774077093490,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Major and Key Cultivation Projects of Ninth People\u2019s Hospital affiliated to Shanghai Jiao Tong University School of Medicine","award":["JYZP005"],"award-info":[{"award-number":["JYZP005"]}]},{"name":"Treatment and mechanism of PI3K\/mTOR dual-target inhibitor (WX390) on PIK3CA-related overgrowth spectrum","award":["JYWO22075"],"award-info":[{"award-number":["JYWO22075"]}]},{"name":"Shanghai Sailing Program","award":["22YF1421900"],"award-info":[{"award-number":["22YF1421900"]}]},{"name":"Rare Disease Registration Platform of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["JYHJB02"],"award-info":[{"award-number":["JYHJB02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00438-024-02159-w","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T04:01:51Z","timestamp":1720497711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delineation of the phenotypes and genotypes of PIK3CA-related overgrowth spectrum in East asians"],"prefix":"10.1007","volume":"299","author":[{"given":"Hongrui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-1367","authenticated-orcid":false,"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"12","key":"2159_CR44","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41416-023-02221-1","volume":"128","author":"C Belli","year":"2023","unstructured":"Belli C, Repetto M, Anand S, Porta C, Subbiah V, Curigliano G (2023) The emerging role of PI3K inhibitors for solid tumour treatment and beyond. Br J Cancer 128(12):2150\u20132162","journal-title":"Br J Cancer"},{"issue":"6","key":"2159_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/pde.14302","volume":"37","author":"C Briand","year":"2020","unstructured":"Briand C, Galmiche-Rolland L, Vabres P, Couloigner V, Audebert S, Misery L et al (2020) Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation. Pediatr Dermatol 37(6):1128\u20131130","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2159_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13023-021-01898-y","volume":"16","author":"P Brouillard","year":"2021","unstructured":"Brouillard P, Schlogel MJ, Homayun Sepehr N, Helaers R, Queisser A, Fastre E et al (2021) Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations. Orphanet J Rare Dis 16(1):267","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2159_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","volume":"16","author":"G Canaud","year":"2021","unstructured":"Canaud G, Hammill AM, Adams D, Vikkula M, Keppler-Noreuil KM (2021) A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis 16(1):306","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"2159_CR48","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.gim.2023.100969","volume":"25","author":"G Canaud","year":"2023","unstructured":"Canaud G, Lopez Gutierrez JC, Irvine AD, Vabres P, Hansford JR, Ankrah N et al (2023) Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS). Genet Med 25(12):100969","journal-title":"Genet Med"},{"issue":"8","key":"2159_CR30","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.bjps.2020.11.032","volume":"74","author":"W Chen","year":"2021","unstructured":"Chen W, Tian X, Chen L, Huang W (2021) Macrodactyly of the foot resulting from plantar nerve impairment. J Plast Reconstr Aesthet Surg 74(8):1840\u20131847","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"2159_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13023-023-02786-3","volume":"18","author":"H Chen","year":"2023","unstructured":"Chen H, Sun B, Gao W, Qiu Y, Hua C, Lin X (2023) Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations. Orphanet J Rare Dis 18(1):189","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2159_CR43","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/s41436-021-01211-z","volume":"23","author":"CE Cottrell","year":"2021","unstructured":"Cottrell CE, Bender NR, Zimmermann MT, Heusel JW, Corliss M, Evenson MJ et al (2021) Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth. Genet Med 23(10):1882\u20131888","journal-title":"Genet Med"},{"issue":"5","key":"2159_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/pr.2017.155","volume":"82","author":"JA Couto","year":"2017","unstructured":"Couto JA, Konczyk DJ, Vivero MP, Kozakewich HPW, Upton J, Fu X et al (2017) Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis. Pediatr Res 82(5):850\u2013854","journal-title":"Pediatr Res"},{"key":"2159_CR12","doi-asserted-by":"crossref","unstructured":"Diociaiuti A, Rotunno R, Pisaneschi E, Cesario C, Carnevale C, Condorelli AG et al (2022) Clinical and molecular spectrum of sporadic vascular malformations: a single-center study. Biomedicines, 10(6)","DOI":"10.3390\/biomedicines10061460"},{"issue":"24","key":"2159_CR40","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1158\/0008-5472.CAN-15-1654","volume":"75","author":"T Dogruluk","year":"2015","unstructured":"Dogruluk T, Tsang YH, Espitia M, Chen F, Chen T, Chong Z et al (2015) Identification of variant-specific functions of PIK3CA by Rapid phenotyping of rare mutations. Cancer Res 75(24):5341\u20135354","journal-title":"Cancer Res"},{"key":"2159_CR54","doi-asserted-by":"crossref","unstructured":"Ermira Pazolli RK (2021) RLY-2608: the first allosteric mutant- and isoform-selective inhibitor of PI3K\u03b1, is efficacious as a single agent and drives regressions in combination with standard of care therapies in PIK3CA mutant breast cancer models San Antonio Breast Cancer Symposium, December 7\u201310","DOI":"10.1158\/1538-7445.SABCS21-P5-16-10"},{"issue":"3","key":"2159_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00109-020-02030-6","volume":"99","author":"AP Garneau","year":"2021","unstructured":"Garneau AP, Haydock L, Tremblay LE, Isenring P (2021) Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America. J Mol Med (Berl) 99(3):311\u2013313","journal-title":"J Mol Med (Berl)"},{"key":"2159_CR50","doi-asserted-by":"crossref","unstructured":"Garreta Fontelles G, Pardo Pastor J, Grande C, Moreillo (2022) Alpelisib to treat CLOVES syndrome, a member of the PIK3CA-related overgrowth syndrome spectrum. Br J Clin Pharmacol","DOI":"10.22541\/au.163890275.58839981\/v3"},{"issue":"21","key":"2159_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1056\/NEJMra1704560","volume":"379","author":"MD Goncalves","year":"2018","unstructured":"Goncalves MD, Hopkins BD, Cantley LC (2018) Phosphatidylinositol 3-Kinase, Growth disorders, and Cancer. N Engl J Med 379(21):2052\u20132062","journal-title":"N Engl J Med"},{"issue":"5","key":"2159_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/cge.13702","volume":"97","author":"JA Goss","year":"2020","unstructured":"Goss JA, Konczyk DJ, Smits P, Sudduth CL, Bischoff J, Liang MG et al (2020) Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants. Clin Genet 97(5):736\u2013740","journal-title":"Clin Genet"},{"key":"2159_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41439-019-0063-9","volume":"6","author":"H Hanafusa","year":"2019","unstructured":"Hanafusa H, Morisada N, Nomura T, Kobayashi D, Akasaka Y, Ye MJ et al (2019) A girl with CLOVES syndrome with a recurrent PIK3CA somatic mutation and pancreatic steatosis. Hum Genome Var 6:31","journal-title":"Hum Genome Var"},{"issue":"3","key":"2159_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1158\/2159-8290.CD-22-0764","volume":"13","author":"AN Holowatyj","year":"2023","unstructured":"Holowatyj AN, Wen W, Gibbs T, Seagle HM, Keller SR, Edwards DRV et al (2023) Racial\/Ethnic and sex differences in somatic Cancer gene mutations among patients with early-onset Colorectal Cancer. Cancer Discov 13(3):570\u2013579","journal-title":"Cancer Discov"},{"issue":"1","key":"2159_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13000-022-01199-3","volume":"17","author":"Y Hori","year":"2022","unstructured":"Hori Y, Hirose K, Ozeki M, Hata K, Motooka D, Tahara S et al (2022) PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in fibfibroipose vascular anomaly (FAVA). Diagn Pathol 17(1):19","journal-title":"Diagn Pathol"},{"issue":"12","key":"2159_CR1","first-page":"7677","volume":"13","author":"P Hu","year":"1993","unstructured":"Hu P, Mondino A, Skolnik EY, Schlessinger J (1993) Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol 13(12):7677\u20137688","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2159_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/neup.12875","volume":"43","author":"K Itoh","year":"2023","unstructured":"Itoh K, Pooh R, Shimokawa O, Fushiki S (2023) Somatic mosaicism of the PI3K-AKT-MTOR pathway is associated with hemimegalencephaly in fetal brains. Neuropathology 43(2):190\u2013196","journal-title":"Neuropathology"},{"issue":"2","key":"2159_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167A","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC et al (2015) PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 167A(2):287\u2013295","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2159_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ajmg.c.31531","volume":"172","author":"KM Keppler-Noreuil","year":"2016","unstructured":"Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA (2016) Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 172(4):402\u2013421","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"2159_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12920-022-01362-1","volume":"15","author":"YM Kim","year":"2022","unstructured":"Kim YM, Lee Y, Choi Y, Choi IH, Heo SH, Choi JM et al (2022) Clinical and genetic analyses of patients with lateralized overgrowth. BMC Med Genomics 15(1):206","journal-title":"BMC Med Genomics"},{"issue":"9","key":"2159_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/gim.2016.220","volume":"19","author":"P Kuentz","year":"2017","unstructured":"Kuentz P, St-Onge J, Duffourd Y, Courcet JB, Carmignac V, Jouan T et al (2017) Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet Med 19(9):989\u2013997","journal-title":"Genet Med"},{"key":"2159_CR19","first-page":"55","volume":"15","author":"JF Li","year":"2022","unstructured":"Li JF, Tian GL, Pan H, Zhang WT, Li DC, Liu JD et al (2022) An analysis of the pathogenic genes and Mutation sites of Macrodactyly. Pharmgenomics Pers Med 15:55\u201364","journal-title":"Pharmgenomics Pers Med"},{"issue":"4","key":"2159_CR14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","volume":"166","author":"VL Luks","year":"2015","unstructured":"Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovee JV et al (2015) Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 166(4):1048\u20131054e1041","journal-title":"J Pediatr"},{"issue":"1","key":"2159_CR15","doi-asserted-by":"publisher","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","volume":"133","author":"RA Maclellan","year":"2014","unstructured":"Maclellan RA, Luks VL, Vivero MP, Mulliken JB, Zurakowski D, Padwa BL et al (2014) PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg 133(1):12e\u201319e","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"2159_CR39","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2018.08.003","volume":"24","author":"RR Madsen","year":"2018","unstructured":"Madsen RR, Vanhaesebroeck B, Semple RK (2018) Cancer-Associated PIK3CA mutations in Overgrowth disorders. Trends Mol Med 24(10):856\u2013870","journal-title":"Trends Mol Med"},{"key":"2159_CR7","doi-asserted-by":"crossref","unstructured":"Mirzaa G, Timms AE, Conti V, Boyle EA, Girisha KM, Martin B et al (2016) PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight, 1(9)","DOI":"10.1172\/jci.insight.87623"},{"key":"2159_CR42","doi-asserted-by":"crossref","unstructured":"Morgos DT, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S et al (2024) Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric Cancer. Int J Mol Sci, 25(3)","DOI":"10.3390\/ijms25031848"},{"key":"2159_CR53","doi-asserted-by":"crossref","unstructured":"Morin G, Degrugillier-Chopinet C, Vincent M, Fraissenon A, Aubert H, Chapelle C et al (2022) Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib. J Exp Med, 219(3)","DOI":"10.1084\/jem.20212148"},{"issue":"2","key":"2159_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2021-108093","volume":"60","author":"A Mussa","year":"2023","unstructured":"Mussa A, Leoni C, Iacoviello M, Carli D, Ranieri C, Pantaleo A et al (2023) Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants. J Med Genet 60(2):163\u2013173","journal-title":"J Med Genet"},{"key":"2159_CR51","doi-asserted-by":"publisher","first-page":"732836","DOI":"10.3389\/fped.2021.732836","volume":"9","author":"A Pagliazzi","year":"2021","unstructured":"Pagliazzi A, Oranges T, Traficante G, Trapani C, Facchini F, Martin A et al (2021) PIK3CA-Related overgrowth Spectrum from diagnosis to targeted therapy: a case of CLOVES syndrome treated with Alpelisib. Front Pediatr 9:732836","journal-title":"Front Pediatr"},{"issue":"1","key":"2159_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13023-020-01480-y","volume":"15","author":"HJ Park","year":"2020","unstructured":"Park HJ, Shin CH, Yoo WJ, Cho TJ, Kim MJ, Seong MW et al (2020) Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations. Orphanet J Rare Dis 15(1):205","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2159_CR8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41431-023-01414-9","volume":"31","author":"G Reynolds","year":"2023","unstructured":"Reynolds G, Cardaropoli S, Carli D, Luca M, Gazzin A, Coppo P et al (2023) Epidemiology of the disorders of the Pik3ca-related overgrowth spectrum (pros). Eur J Hum Genet 31(11):1333\u20131336","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2159_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"8","key":"2159_CR45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"JB Riviere","year":"2012","unstructured":"Riviere JB, Mirzaa GM, O\u2019Roak BJ, Beddaoui M, Alcantara D, Conway RL et al (2012) De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44(8):934\u2013940","journal-title":"Nat Genet"},{"issue":"1","key":"2159_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13023-023-02893-1","volume":"18","author":"Y Sasaki","year":"2023","unstructured":"Sasaki Y, Ishikawa K, Hatanaka KC, Oyamada Y, Sakuhara Y, Shimizu T et al (2023) Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population: list the full names and institutional addresses for all authors. Orphanet J Rare Dis 18(1):270","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2159_CR33","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-019-02052-6","volume":"138","author":"NS Sim","year":"2019","unstructured":"Sim NS, Ko A, Kim WK, Kim SH, Kim JS, Shim KW et al (2019) Precise detection of low-level somatic mutation in resected epilepsy brain tissue. Acta Neuropathol 138(6):901\u2013912","journal-title":"Acta Neuropathol"},{"key":"2159_CR49","doi-asserted-by":"crossref","unstructured":"Singh S, Bradford D, Li X, Mishra-Kalyani PS, Shen YL, Wang L et al (2023) FDA approval Summary: Alpelisib for PIK3CA-related overgrowth spectrum (PROS). Clin Cancer Res","DOI":"10.1158\/1078-0432.c.7010470.v1"},{"issue":"28","key":"2159_CR25","doi-asserted-by":"publisher","first-page":"45470","DOI":"10.18632\/oncotarget.17566","volume":"8","author":"Y Suzuki","year":"2017","unstructured":"Suzuki Y, Enokido Y, Yamada K, Inaba M, Kuwata K, Hanada N et al (2017) The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K\/AKT\/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS). Oncotarget 8(28):45470\u201345483","journal-title":"Oncotarget"},{"issue":"1","key":"2159_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13023-020-01572-9","volume":"15","author":"W Tian","year":"2020","unstructured":"Tian W, Huang Y, Sun L, Guo Y, Zhao S, Lin M et al (2020) Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants. Orphanet J Rare Dis 15(1):288","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2159_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00438-022-01853-x","volume":"297","author":"W Tian","year":"2022","unstructured":"Tian W, Sun L, Zhang Q, Zhao J, Guo Y, Zhong W et al (2022) Activating PIK3CA postzygotic mutations in segmental overgrowth of muscles with bone involvement in the body extremities. Mol Genet Genomics 297(2):387\u2013396","journal-title":"Mol Genet Genomics"},{"issue":"7711","key":"2159_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP et al (2018) Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 558(7711):540\u2013546","journal-title":"Nature"},{"issue":"7","key":"2159_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1177\/1753193418770366","volume":"43","author":"J Wu","year":"2018","unstructured":"Wu J, Tian W, Tian G, Sumner K, Hutchinson DT, Ji Y (2018) An investigation of PIK3CA mutations in isolated macrodactyly. J Hand Surg Eur Vol 43(7):756\u2013760","journal-title":"J Hand Surg Eur Vol"},{"key":"2159_CR23","doi-asserted-by":"crossref","unstructured":"Wu J, Tian G, Ji Y, Higgins JP, Lee WPA (2020) Clinical characteristics of 90 Macrodactyly cases. J Hand Surg Am, 45(10): p. 982 e981-982 e985.","DOI":"10.1016\/j.jhsa.2020.03.002"},{"key":"2159_CR20","doi-asserted-by":"publisher","first-page":"792466","DOI":"10.3389\/fgene.2022.792466","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Liu M, Yuan H, Liu Z, Zhu D (2022) Case Report: primary pleural angiosarcoma in a patient with klippel-trenaunay syndrome. Front Genet 13:792466","journal-title":"Front Genet"},{"issue":"2","key":"2159_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/his.14923","volume":"83","author":"S Xue","year":"2023","unstructured":"Xue S, Liu Q, Zhao Y, Kong L, Fu F, Gong Y et al (2023) Fibroadipose vascular anomaly: a clinicopathological study of 75 cases. Histopathology 83(2):286\u2013297","journal-title":"Histopathology"},{"issue":"1","key":"2159_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41065-021-00184-y","volume":"158","author":"W Yan","year":"2021","unstructured":"Yan W, Zhang B, Wang H, Mo R, Jiang X, Qin W et al (2021) Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K\/AKT\/mTOR pathway. Hereditas 158(1):18","journal-title":"Hereditas"},{"key":"2159_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13229-017-0182-4","volume":"8","author":"KS Yeung","year":"2017","unstructured":"Yeung KS, Tso WWY, Ip JJK, Mak CCY, Leung GKC, Tsang MHY et al (2017a) Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and\/or autism. Mol Autism 8:66","journal-title":"Mol Autism"},{"issue":"4","key":"2159_CR37","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ajmg.a.38105","volume":"173","author":"KS Yeung","year":"2017","unstructured":"Yeung KS, Ip JJ, Chow CP, Kuong EY, Tam PK, Chan GC et al (2017b) Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum. Am J Med Genet A 173(4):978\u2013984","journal-title":"Am J Med Genet A"},{"key":"2159_CR21","doi-asserted-by":"publisher","first-page":"1221745","DOI":"10.3389\/fgene.2023.1221745","volume":"14","author":"Y Yoh","year":"2023","unstructured":"Yoh Y, Shiohama T, Uchida T, Ebata R, Kobayashi H, Okunushi K et al (2023) Case report: progressive pulmonary artery hypertension in a case of megalencephaly-capillary malformation syndrome. Front Genet 14:1221745","journal-title":"Front Genet"},{"issue":"1","key":"2159_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13023-023-02860-w","volume":"18","author":"B Zhang","year":"2023","unstructured":"Zhang B, He R, Xu Z, Sun Y, Wei L, Li L et al (2023) Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations. Orphanet J Rare Dis 18(1):261","journal-title":"Orphanet J Rare Dis"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-024-02159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-024-02159-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-024-02159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T04:02:28Z","timestamp":1720497748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-024-02159-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1007\/s00438-024-02159-w","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Board of Shanghai Ninth Hospital, Shanghai Jiaotong University of Medicine (SH9H-2021-C46). Written informed consent forms were signed by patients whose photographs were presented in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent for publication was acquired from patients or patients\u2019 parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}